Legislation Roe v. Wade State Legislation Supreme Court State Laws Reproductive Rights Public Opinion Ballot Measures Supreme Court Decisions Ohio Democratic Party Reproductive Health Supreme Court Rulings Republican Party Women's Health Ballot Initiatives State Constitutional Amendments Anti-Abortion Movement Pro-Life Movement Constitutional Amendments Judicial Decisions State Constitution Mifepristone Protests Legal Challenges FDA Approval State Constitutions Anti-Abortion Groups State Elections Presidential Candidates Pro-life Movement Lawsuits Abortion Access Republican Stance State Bans Medication Abortion Abortion Bans Women's Rights Supreme Court Ruling Legislative Actions Abortion Ballot Measures State Politics State Referendums FDA Approval of Mifepristone Ohio Constitutional Amendment Vice President Kamala Harris Advocacy Groups State Supreme Court Michigan Conservative Movements State Restrictions Supreme Court Decision 2024 Presidential Election Reproductive Freedom Restrictions on Abortion President Biden Elections Legislative Control State Constitution Amendments Texas Legal Decisions State Protections Access to Medication Abortion Opposition Abortion Restrictions National Abortion Ban U.S. Supreme Court State Amendments Joe Biden Healthcare Policy Legal Issues Anti-Abortion Advocates Advocacy Republican Presidential Candidates Conservative Opposition Roe v. Wade Reversal Donald Trump Abortion Pill 2024 Elections Federal Ban Texas Abortion Ban Federal Law State Legislatures Ohio Ballot Measure FDA Regulations Roe v Wade Republican Candidates State-Level Bans Activism Dobbs Decision Referendums Kentucky Federal Funding Virginia Election Results Florida State Laws Contraception Access Reproductive Rights Advocates State Budget State Ballot Measures
The findings are now a rallying point for efforts to curb telehealth dispensing of mifepristone.
